-+ 0.00%
-+ 0.00%
-+ 0.00%

Monte Rosa Therapeutics Announces New Phase 2 Trial of MRT-2359 in mCRPC Patients with AR Mutations

Reuters·12/16/2025 12:02:06

Please log in to view news